Douglas Eric Raines, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Etomidate | 36 | 2022 | 190 | 14.920 |
Why?
|
| Hypnotics and Sedatives | 24 | 2021 | 1162 | 5.970 |
Why?
|
| Receptors, GABA-A | 27 | 2022 | 627 | 4.330 |
Why?
|
| Anesthetics, Intravenous | 9 | 2018 | 417 | 2.970 |
Why?
|
| Adrenal Cortex | 9 | 2018 | 140 | 2.880 |
Why?
|
| Anesthetics, Inhalation | 24 | 2018 | 570 | 2.600 |
Why?
|
| Receptors, Nicotinic | 22 | 2012 | 497 | 2.170 |
Why?
|
| Anesthetics | 10 | 2021 | 539 | 2.140 |
Why?
|
| Receptors, Serotonin, 5-HT3 | 9 | 2013 | 43 | 1.770 |
Why?
|
| Steroid 11-beta-Hydroxylase | 3 | 2018 | 20 | 1.680 |
Why?
|
| Xenopus laevis | 26 | 2020 | 957 | 1.630 |
Why?
|
| Diazepam | 3 | 2022 | 205 | 1.610 |
Why?
|
| Pyrroles | 8 | 2016 | 1146 | 1.510 |
Why?
|
| Propofol | 9 | 2022 | 629 | 1.420 |
Why?
|
| Receptors, GABA | 4 | 2020 | 288 | 1.370 |
Why?
|
| Anesthetics, General | 8 | 2012 | 152 | 1.080 |
Why?
|
| gamma-Aminobutyric Acid | 10 | 2022 | 1121 | 1.040 |
Why?
|
| Rats, Sprague-Dawley | 22 | 2019 | 8301 | 1.030 |
Why?
|
| Ion Channel Gating | 12 | 2015 | 437 | 0.980 |
Why?
|
| Flumazenil | 3 | 2021 | 84 | 0.980 |
Why?
|
| Reflex | 5 | 2019 | 365 | 0.960 |
Why?
|
| GABA-A Receptor Agonists | 5 | 2011 | 84 | 0.940 |
Why?
|
| Binding, Competitive | 5 | 2020 | 1157 | 0.930 |
Why?
|
| GABA Antagonists | 3 | 2017 | 128 | 0.840 |
Why?
|
| Reflex, Righting | 4 | 2018 | 18 | 0.840 |
Why?
|
| Naphthalenes | 2 | 2020 | 194 | 0.820 |
Why?
|
| Dose-Response Relationship, Drug | 23 | 2020 | 10943 | 0.820 |
Why?
|
| Isoflurane | 11 | 2008 | 380 | 0.790 |
Why?
|
| GABA-A Receptor Antagonists | 3 | 2020 | 62 | 0.790 |
Why?
|
| Rats | 25 | 2019 | 24260 | 0.760 |
Why?
|
| Structure-Activity Relationship | 15 | 2018 | 3129 | 0.750 |
Why?
|
| Larva | 10 | 2018 | 519 | 0.750 |
Why?
|
| Nicotinic Antagonists | 6 | 2012 | 96 | 0.740 |
Why?
|
| Torpedo | 19 | 2011 | 169 | 0.730 |
Why?
|
| GABA Modulators | 2 | 2020 | 107 | 0.720 |
Why?
|
| Oocytes | 16 | 2018 | 1187 | 0.680 |
Why?
|
| Nicotinic Agonists | 6 | 2002 | 271 | 0.670 |
Why?
|
| Alkanes | 3 | 2003 | 45 | 0.640 |
Why?
|
| Propanolamines | 1 | 2018 | 167 | 0.600 |
Why?
|
| Animals | 74 | 2022 | 168757 | 0.590 |
Why?
|
| Adrenocorticotropic Hormone | 3 | 2018 | 648 | 0.590 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 8 | 2012 | 895 | 0.570 |
Why?
|
| Steroids | 2 | 2019 | 930 | 0.540 |
Why?
|
| Halothane | 5 | 2007 | 206 | 0.540 |
Why?
|
| Pulmonary Alveoli | 8 | 2008 | 675 | 0.520 |
Why?
|
| Adrenal Cortex Diseases | 2 | 2014 | 13 | 0.480 |
Why?
|
| Serotonin 5-HT3 Receptor Antagonists | 2 | 2013 | 18 | 0.480 |
Why?
|
| Biotransformation | 4 | 2018 | 168 | 0.450 |
Why?
|
| Excitatory Amino Acid Antagonists | 5 | 2020 | 449 | 0.440 |
Why?
|
| Electroencephalography | 6 | 2019 | 6150 | 0.430 |
Why?
|
| Patch-Clamp Techniques | 9 | 2012 | 964 | 0.430 |
Why?
|
| Hydrocarbons, Aromatic | 4 | 2009 | 23 | 0.430 |
Why?
|
| Kinetics | 15 | 2012 | 6473 | 0.420 |
Why?
|
| Membrane Potentials | 8 | 2012 | 1137 | 0.410 |
Why?
|
| Carboxylic Acids | 1 | 2011 | 97 | 0.400 |
Why?
|
| Infusions, Intravenous | 5 | 2015 | 2274 | 0.390 |
Why?
|
| Binding Sites | 7 | 2021 | 6114 | 0.380 |
Why?
|
| Carbon | 1 | 2014 | 687 | 0.370 |
Why?
|
| Serotonin | 4 | 2007 | 1017 | 0.370 |
Why?
|
| Endotoxemia | 1 | 2012 | 207 | 0.370 |
Why?
|
| Benzene Derivatives | 1 | 2009 | 54 | 0.360 |
Why?
|
| Electrophysiology | 7 | 2010 | 1308 | 0.350 |
Why?
|
| Zebrafish | 4 | 2022 | 2994 | 0.350 |
Why?
|
| GABA Agonists | 2 | 2014 | 111 | 0.330 |
Why?
|
| Hydrocarbons, Halogenated | 2 | 2009 | 20 | 0.310 |
Why?
|
| Seizures | 2 | 2019 | 2859 | 0.310 |
Why?
|
| Lipopolysaccharides | 1 | 2015 | 2216 | 0.310 |
Why?
|
| Dansyl Compounds | 4 | 2000 | 20 | 0.300 |
Why?
|
| Fatty Alcohols | 1 | 2007 | 23 | 0.300 |
Why?
|
| Alcohols | 3 | 2005 | 92 | 0.300 |
Why?
|
| Corticosterone | 3 | 2013 | 310 | 0.290 |
Why?
|
| Spectrometry, Fluorescence | 7 | 2006 | 689 | 0.290 |
Why?
|
| Pentobarbital | 1 | 2007 | 155 | 0.290 |
Why?
|
| Lipid Bilayers | 4 | 2000 | 381 | 0.290 |
Why?
|
| Hydrocortisone | 4 | 2021 | 1826 | 0.280 |
Why?
|
| Information Management | 1 | 2007 | 101 | 0.280 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 1889 | 0.280 |
Why?
|
| Half-Life | 3 | 2012 | 661 | 0.280 |
Why?
|
| Receptors, Serotonin | 1 | 2007 | 201 | 0.280 |
Why?
|
| Diazomethane | 3 | 2011 | 36 | 0.270 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 3 | 2020 | 407 | 0.270 |
Why?
|
| Dopamine | 3 | 2007 | 1591 | 0.270 |
Why?
|
| Anesthesia | 4 | 2014 | 1561 | 0.270 |
Why?
|
| Xenopus | 5 | 2018 | 712 | 0.260 |
Why?
|
| Cerebrospinal Fluid | 1 | 2008 | 534 | 0.260 |
Why?
|
| Ligands | 8 | 2020 | 3282 | 0.250 |
Why?
|
| Serotonin Receptor Agonists | 1 | 2005 | 152 | 0.250 |
Why?
|
| Methyl Ethers | 1 | 2006 | 205 | 0.240 |
Why?
|
| Hospital Information Systems | 1 | 2007 | 395 | 0.240 |
Why?
|
| Muscle, Skeletal | 1 | 2019 | 4931 | 0.240 |
Why?
|
| Cations | 1 | 2004 | 232 | 0.230 |
Why?
|
| Immobilization | 4 | 2008 | 236 | 0.230 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2007 | 397 | 0.220 |
Why?
|
| Quaternary Ammonium Compounds | 3 | 2000 | 205 | 0.220 |
Why?
|
| Electric Organ | 6 | 2002 | 54 | 0.220 |
Why?
|
| Ketamine | 2 | 2020 | 500 | 0.220 |
Why?
|
| Octanols | 4 | 2011 | 27 | 0.210 |
Why?
|
| Solubility | 6 | 2014 | 1085 | 0.210 |
Why?
|
| Recovery of Function | 1 | 2013 | 2925 | 0.210 |
Why?
|
| Ion Channels | 6 | 2010 | 1056 | 0.210 |
Why?
|
| Dogs | 2 | 2019 | 3912 | 0.210 |
Why?
|
| Models, Animal | 2 | 2020 | 2171 | 0.200 |
Why?
|
| Aprotinin | 1 | 2001 | 88 | 0.200 |
Why?
|
| Sepsis | 1 | 2015 | 2593 | 0.190 |
Why?
|
| Photoaffinity Labels | 3 | 2011 | 86 | 0.190 |
Why?
|
| Drug Antagonism | 1 | 2020 | 50 | 0.190 |
Why?
|
| Rana pipiens | 2 | 2018 | 65 | 0.190 |
Why?
|
| Fluorobenzenes | 3 | 2007 | 183 | 0.190 |
Why?
|
| Membranes | 4 | 2002 | 173 | 0.190 |
Why?
|
| Drug Discovery | 2 | 2019 | 1058 | 0.190 |
Why?
|
| Documentation | 1 | 2007 | 871 | 0.190 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 18029 | 0.190 |
Why?
|
| Porphyria, Hepatoerythropoietic | 1 | 1999 | 8 | 0.180 |
Why?
|
| DNA, Complementary | 4 | 2005 | 2050 | 0.170 |
Why?
|
| Photosensitivity Disorders | 1 | 1999 | 78 | 0.170 |
Why?
|
| HEK293 Cells | 3 | 2020 | 4204 | 0.170 |
Why?
|
| Synaptic Membranes | 3 | 1998 | 91 | 0.170 |
Why?
|
| Liver Transplantation | 2 | 2001 | 2119 | 0.170 |
Why?
|
| Proteins | 3 | 2006 | 6103 | 0.170 |
Why?
|
| Hemostatics | 1 | 2001 | 229 | 0.160 |
Why?
|
| Hypnosis, Anesthetic | 1 | 2018 | 7 | 0.160 |
Why?
|
| Stereoisomerism | 3 | 2014 | 624 | 0.160 |
Why?
|
| Receptors, Muscarinic | 1 | 1998 | 156 | 0.160 |
Why?
|
| Allosteric Regulation | 5 | 2015 | 408 | 0.160 |
Why?
|
| Male | 26 | 2019 | 350118 | 0.160 |
Why?
|
| Cytokines | 1 | 2012 | 7322 | 0.140 |
Why?
|
| Fluorescent Dyes | 3 | 2001 | 1917 | 0.140 |
Why?
|
| Eisenmenger Complex | 1 | 1996 | 27 | 0.140 |
Why?
|
| Azirines | 2 | 2012 | 30 | 0.140 |
Why?
|
| Chemistry, Physical | 3 | 2002 | 156 | 0.140 |
Why?
|
| Anesthetics, Dissociative | 1 | 2016 | 80 | 0.140 |
Why?
|
| Drug Interactions | 3 | 2007 | 1460 | 0.140 |
Why?
|
| Chemical Phenomena | 3 | 2002 | 518 | 0.140 |
Why?
|
| GABA Agents | 1 | 2015 | 42 | 0.140 |
Why?
|
| Convulsants | 1 | 2015 | 70 | 0.130 |
Why?
|
| Blood Pressure | 1 | 2011 | 8554 | 0.130 |
Why?
|
| Electrophysiological Phenomena | 1 | 2017 | 315 | 0.130 |
Why?
|
| Protein Conformation | 6 | 2006 | 4011 | 0.130 |
Why?
|
| Molecular Structure | 4 | 2012 | 1899 | 0.130 |
Why?
|
| Benzodiazepines | 1 | 2021 | 1101 | 0.130 |
Why?
|
| Butanols | 1 | 1995 | 19 | 0.130 |
Why?
|
| Movement | 2 | 2017 | 1471 | 0.130 |
Why?
|
| Light | 2 | 2012 | 1374 | 0.130 |
Why?
|
| Phenobarbital | 1 | 2015 | 193 | 0.130 |
Why?
|
| Female | 21 | 2020 | 380194 | 0.130 |
Why?
|
| Postural Balance | 2 | 2010 | 620 | 0.130 |
Why?
|
| Lethal Dose 50 | 1 | 2014 | 77 | 0.130 |
Why?
|
| Fluorescence | 4 | 1999 | 751 | 0.130 |
Why?
|
| Thromboembolism | 1 | 2001 | 986 | 0.120 |
Why?
|
| Phosphatidylcholines | 5 | 1998 | 411 | 0.120 |
Why?
|
| Anesthesia, Local | 1 | 1996 | 275 | 0.120 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1999 | 685 | 0.120 |
Why?
|
| Humans | 39 | 2021 | 744343 | 0.120 |
Why?
|
| Cycloparaffins | 1 | 1993 | 12 | 0.120 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2014 | 281 | 0.120 |
Why?
|
| Indicators and Reagents | 1 | 2014 | 462 | 0.110 |
Why?
|
| Butanes | 2 | 2003 | 7 | 0.110 |
Why?
|
| Cyclopropanes | 3 | 2004 | 416 | 0.110 |
Why?
|
| Molecular Conformation | 1 | 2014 | 563 | 0.110 |
Why?
|
| Methanol | 1 | 1993 | 85 | 0.110 |
Why?
|
| Mephobarbital | 1 | 2012 | 7 | 0.110 |
Why?
|
| 1-Butanol | 2 | 2007 | 13 | 0.110 |
Why?
|
| Azo Compounds | 1 | 2012 | 113 | 0.110 |
Why?
|
| Brain | 5 | 2016 | 26385 | 0.110 |
Why?
|
| Membrane Lipids | 1 | 1993 | 248 | 0.100 |
Why?
|
| Depression, Chemical | 1 | 2011 | 191 | 0.100 |
Why?
|
| Esters | 1 | 2012 | 210 | 0.100 |
Why?
|
| Blood Pressure Monitors | 1 | 1991 | 33 | 0.100 |
Why?
|
| Hospital Costs | 1 | 2018 | 985 | 0.100 |
Why?
|
| Drug Stability | 1 | 2011 | 291 | 0.100 |
Why?
|
| Chromatography, Gas | 2 | 2008 | 156 | 0.100 |
Why?
|
| Heme | 1 | 2013 | 307 | 0.100 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 1678 | 0.100 |
Why?
|
| Deep Sedation | 1 | 2012 | 121 | 0.090 |
Why?
|
| Spinal Cord | 3 | 2008 | 1809 | 0.090 |
Why?
|
| Electron Spin Resonance Spectroscopy | 5 | 1995 | 165 | 0.090 |
Why?
|
| Area Under Curve | 1 | 2014 | 1654 | 0.090 |
Why?
|
| Injections, Spinal | 2 | 2008 | 303 | 0.090 |
Why?
|
| Drug Costs | 1 | 2018 | 1105 | 0.090 |
Why?
|
| Models, Chemical | 2 | 2006 | 626 | 0.090 |
Why?
|
| Esterases | 1 | 2009 | 95 | 0.090 |
Why?
|
| Anesthesia, General | 2 | 1996 | 1171 | 0.090 |
Why?
|
| Hemodynamics | 2 | 2010 | 4199 | 0.090 |
Why?
|
| Hydroxides | 1 | 1989 | 47 | 0.080 |
Why?
|
| Hexanols | 2 | 2007 | 6 | 0.080 |
Why?
|
| Monitoring, Intraoperative | 2 | 1996 | 957 | 0.080 |
Why?
|
| Electrochemistry | 2 | 2002 | 145 | 0.080 |
Why?
|
| Pulmonary Embolism | 1 | 2001 | 2376 | 0.080 |
Why?
|
| Potassium Chloride | 1 | 2008 | 237 | 0.080 |
Why?
|
| Acetylcholine | 3 | 1999 | 621 | 0.080 |
Why?
|
| Adrenal Cortex Neoplasms | 1 | 2010 | 162 | 0.080 |
Why?
|
| Random Allocation | 1 | 2013 | 2429 | 0.080 |
Why?
|
| Motor Activity | 3 | 2009 | 2714 | 0.080 |
Why?
|
| Volatilization | 1 | 2007 | 82 | 0.080 |
Why?
|
| Anesthesia, Inhalation | 1 | 1989 | 223 | 0.080 |
Why?
|
| Algorithms | 7 | 2005 | 13881 | 0.080 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2011 | 1572 | 0.080 |
Why?
|
| 1-Octanol | 1 | 2007 | 7 | 0.080 |
Why?
|
| 1-Propanol | 1 | 2007 | 15 | 0.080 |
Why?
|
| Osmolar Concentration | 1 | 2008 | 683 | 0.070 |
Why?
|
| Heart | 1 | 2021 | 4467 | 0.070 |
Why?
|
| Time Factors | 6 | 2018 | 40075 | 0.070 |
Why?
|
| Receptors, Cholinergic | 3 | 2008 | 238 | 0.070 |
Why?
|
| Benzophenones | 1 | 2006 | 57 | 0.070 |
Why?
|
| Microinjections | 1 | 2007 | 327 | 0.070 |
Why?
|
| Behavior, Animal | 1 | 2014 | 1881 | 0.070 |
Why?
|
| Pharmaceutical Preparations | 1 | 1994 | 1071 | 0.070 |
Why?
|
| Cell Line, Transformed | 1 | 2007 | 898 | 0.070 |
Why?
|
| Interleukin-10 | 1 | 2012 | 1200 | 0.070 |
Why?
|
| Drug Synergism | 2 | 2008 | 1792 | 0.070 |
Why?
|
| Interleukin-1beta | 1 | 2012 | 972 | 0.070 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2007 | 876 | 0.070 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2006 | 146 | 0.070 |
Why?
|
| Benzene | 1 | 2006 | 100 | 0.070 |
Why?
|
| Chloroform | 1 | 2005 | 28 | 0.070 |
Why?
|
| Anticonvulsants | 1 | 2015 | 1916 | 0.070 |
Why?
|
| Protein Binding | 1 | 2018 | 9386 | 0.070 |
Why?
|
| Spin Labels | 4 | 1995 | 332 | 0.070 |
Why?
|
| Ethanol | 2 | 2007 | 1342 | 0.070 |
Why?
|
| Liposomes | 4 | 1995 | 759 | 0.060 |
Why?
|
| Health Expenditures | 1 | 2018 | 2348 | 0.060 |
Why?
|
| Water | 1 | 2011 | 1395 | 0.060 |
Why?
|
| Models, Biological | 5 | 2009 | 9583 | 0.060 |
Why?
|
| RNA, Messenger | 3 | 2010 | 13033 | 0.060 |
Why?
|
| Drug Design | 1 | 2010 | 1076 | 0.060 |
Why?
|
| Stearic Acids | 2 | 1995 | 53 | 0.060 |
Why?
|
| Lipid Metabolism | 1 | 1993 | 1889 | 0.060 |
Why?
|
| Potassium | 1 | 2008 | 1336 | 0.060 |
Why?
|
| Analgesia | 1 | 2008 | 461 | 0.060 |
Why?
|
| Flurothyl | 1 | 2002 | 10 | 0.060 |
Why?
|
| Biophysical Phenomena | 2 | 1995 | 327 | 0.060 |
Why?
|
| Protons | 1 | 1989 | 1127 | 0.060 |
Why?
|
| Chlorofluorocarbons | 1 | 2002 | 12 | 0.060 |
Why?
|
| Biophysics | 2 | 1995 | 383 | 0.050 |
Why?
|
| Sodium | 1 | 2008 | 1623 | 0.050 |
Why?
|
| Catheterization | 1 | 2008 | 1470 | 0.050 |
Why?
|
| Cyclobutanes | 1 | 2002 | 59 | 0.050 |
Why?
|
| Protein Structure, Secondary | 1 | 2006 | 1246 | 0.050 |
Why?
|
| Electric Stimulation | 1 | 2007 | 1767 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2007 | 1730 | 0.050 |
Why?
|
| Administration, Inhalation | 1 | 2005 | 1105 | 0.050 |
Why?
|
| Hydrogen Bonding | 1 | 2002 | 293 | 0.050 |
Why?
|
| Orosomucoid | 1 | 2001 | 45 | 0.050 |
Why?
|
| Fluorocarbons | 1 | 2007 | 452 | 0.050 |
Why?
|
| Interleukin-6 | 1 | 2012 | 3200 | 0.050 |
Why?
|
| Microelectrodes | 1 | 2003 | 303 | 0.050 |
Why?
|
| Models, Molecular | 4 | 2012 | 5456 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2010 | 1723 | 0.050 |
Why?
|
| Cysteine | 1 | 2006 | 874 | 0.050 |
Why?
|
| Reaction Time | 1 | 2007 | 2097 | 0.050 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2007 | 1205 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2009 | 1855 | 0.050 |
Why?
|
| Motion | 2 | 1995 | 798 | 0.050 |
Why?
|
| Cystectomy | 1 | 2005 | 686 | 0.040 |
Why?
|
| Cholinergic Agents | 1 | 2000 | 93 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2014 | 5102 | 0.040 |
Why?
|
| Tetralogy of Fallot | 1 | 2005 | 623 | 0.040 |
Why?
|
| Thermodynamics | 2 | 1995 | 596 | 0.040 |
Why?
|
| Phosphatidic Acids | 1 | 1998 | 49 | 0.040 |
Why?
|
| Lipids | 3 | 1994 | 3305 | 0.040 |
Why?
|
| Tennessee | 1 | 2018 | 117 | 0.040 |
Why?
|
| Choline | 1 | 2000 | 493 | 0.040 |
Why?
|
| Wound Healing | 1 | 2008 | 2785 | 0.040 |
Why?
|
| Cell Line | 1 | 2011 | 15997 | 0.040 |
Why?
|
| RNA | 1 | 2007 | 2749 | 0.040 |
Why?
|
| Enflurane | 1 | 1996 | 17 | 0.040 |
Why?
|
| Isomerism | 1 | 2015 | 201 | 0.030 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2018 | 264 | 0.030 |
Why?
|
| Inflammation | 1 | 2015 | 10638 | 0.030 |
Why?
|
| Phospholipids | 2 | 1993 | 784 | 0.030 |
Why?
|
| Serum Albumin | 1 | 1998 | 676 | 0.030 |
Why?
|
| Protein Subunits | 2 | 2010 | 959 | 0.030 |
Why?
|
| Pharmacology | 1 | 1994 | 103 | 0.030 |
Why?
|
| Anesthetics, Local | 1 | 2001 | 985 | 0.030 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2018 | 501 | 0.030 |
Why?
|
| Anesthesia, Epidural | 1 | 1996 | 228 | 0.030 |
Why?
|
| Gases | 1 | 1994 | 197 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2017 | 63114 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1996 | 1681 | 0.030 |
Why?
|
| Gene Expression | 1 | 2007 | 7799 | 0.030 |
Why?
|
| Models, Economic | 1 | 2018 | 713 | 0.030 |
Why?
|
| Transfection | 1 | 2001 | 5892 | 0.030 |
Why?
|
| Reflex, Abnormal | 1 | 1993 | 84 | 0.030 |
Why?
|
| Labor, Obstetric | 1 | 1996 | 333 | 0.030 |
Why?
|
| Cattle | 2 | 2010 | 3922 | 0.030 |
Why?
|
| Photochemical Processes | 1 | 2012 | 84 | 0.030 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2005 | 2245 | 0.030 |
Why?
|
| Conscious Sedation | 1 | 1996 | 528 | 0.030 |
Why?
|
| Fibrinolytic Agents | 1 | 2001 | 2158 | 0.020 |
Why?
|
| Plant Oils | 1 | 2012 | 202 | 0.020 |
Why?
|
| Rotation | 1 | 1993 | 523 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 1993 | 625 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 14722 | 0.020 |
Why?
|
| Radioligand Assay | 1 | 2010 | 374 | 0.020 |
Why?
|
| Nerve Block | 1 | 1996 | 644 | 0.020 |
Why?
|
| Postoperative Care | 1 | 1996 | 1486 | 0.020 |
Why?
|
| Cholesterol | 1 | 1998 | 2917 | 0.020 |
Why?
|
| Delivery, Obstetric | 1 | 1996 | 906 | 0.020 |
Why?
|
| Equipment Failure | 1 | 1991 | 578 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2012 | 1801 | 0.020 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 1 | 2008 | 58 | 0.020 |
Why?
|
| Action Potentials | 1 | 2015 | 1806 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1993 | 2557 | 0.020 |
Why?
|
| Static Electricity | 1 | 2008 | 267 | 0.020 |
Why?
|
| Receptors, Glutamate | 1 | 2008 | 232 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2001 | 6442 | 0.020 |
Why?
|
| Nitrous Oxide | 1 | 2008 | 177 | 0.020 |
Why?
|
| Cesarean Section | 1 | 1996 | 1365 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2018 | 2759 | 0.020 |
Why?
|
| Preoperative Care | 1 | 1996 | 2250 | 0.020 |
Why?
|
| Goats | 1 | 2007 | 171 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 1989 | 590 | 0.020 |
Why?
|
| Sodium Channels | 1 | 2008 | 349 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2001 | 19229 | 0.020 |
Why?
|
| Mice | 4 | 2015 | 81183 | 0.020 |
Why?
|
| Boston | 1 | 2018 | 9313 | 0.020 |
Why?
|
| Cell Membrane | 1 | 1995 | 3748 | 0.020 |
Why?
|
| Middle Aged | 4 | 2018 | 213383 | 0.020 |
Why?
|
| Picrotoxin | 1 | 2004 | 65 | 0.020 |
Why?
|
| Xenon | 1 | 2004 | 110 | 0.010 |
Why?
|
| Neurons | 1 | 2002 | 9338 | 0.010 |
Why?
|
| Survival Rate | 1 | 1996 | 12788 | 0.010 |
Why?
|
| Spectrophotometry | 1 | 2001 | 313 | 0.010 |
Why?
|
| Adult | 3 | 2018 | 214055 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2008 | 3494 | 0.010 |
Why?
|
| Genetic Engineering | 1 | 2003 | 951 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2008 | 3589 | 0.010 |
Why?
|
| Aged | 3 | 2018 | 163280 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2009 | 6196 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2005 | 5078 | 0.010 |
Why?
|
| Photochemistry | 1 | 1994 | 238 | 0.010 |
Why?
|
| Pregnancy | 1 | 1996 | 29144 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 2010 | 5708 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1996 | 41006 | 0.010 |
Why?
|
| Young Adult | 1 | 2018 | 56430 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 19905 | 0.010 |
Why?
|
| Risk Factors | 1 | 1996 | 72290 | 0.010 |
Why?
|
| Child | 1 | 1996 | 77709 | 0.000 |
Why?
|
| Adolescent | 1 | 1996 | 85781 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1996 | 77449 | 0.000 |
Why?
|
| Mice, Knockout | 1 | 2002 | 14557 | 0.000 |
Why?
|
| Research Design | 1 | 2001 | 5987 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 2002 | 21827 | 0.000 |
Why?
|